The CD26/DPPIV plays a key role in many physiological and pathological processes, such as glucose metabolism and chemokine regulation, but also acts as a tumor marker for various types of cancers [73–75], and has a strong association with the severity of disease and comorbidity in patients with COVID-19 [76,77]. This evidence concerns the gene DPP4 and COVID-19.